Treatment of heart failure in adults with thalassemia major: response in patients randomised to deferoxamine with or without deferiprone

BACKGROUND: Established heart failure in thalassaemia major has a poor prognosis and optimal management remains unclear. METHODS: A 1 year prospective study comparing deferoxamine (DFO) monotherapy or when combined with deferiprone (DFP) for patients with left ventricular ejection fraction (LVEF) &l...

Descripción completa

Detalles Bibliográficos
Autores principales: Porter, John B, Wood, John, Olivieri, Nancy, Vichinsky, Elliott P, Taher, Ali, Neufeld, Ellis, Giardina, Patricia, Thompson, Alexis, Moore, Blaine, Evans, Patricia, Kim, Hae-Young, Macklin, Eric A, Trachtenberg, Felicia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669105/
https://www.ncbi.nlm.nih.gov/pubmed/23688265
http://dx.doi.org/10.1186/1532-429X-15-38

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669105/
https://www.ncbi.nlm.nih.gov/pubmed/23688265
http://dx.doi.org/10.1186/1532-429X-15-38

Ejemplares similares